In 2023, McDermott Will & Emery experienced steady growth with a significant number of large health care merger, acquisition, and litigation matters. The firm’s gross revenue rose by 5.8% to $1.92 billion, and its profits per equity partner skyrocketed by almost 13%. Resolve despite a minor 2% drop in its equity tier, the firm’s net income for equity partners went up by 10.5%. To put these figures into perspective, the profit per equity for the year 2023 was $3.76 million. In contrast, in 2018, the PEP was $1.88 million, which is about half the amount of 2023. This marked a historic high for the firm. (Read more)
On the geographic performance front, whereas the firm admitted to certain underperformance in Europe as compared to US outputs, London emerged with a commendable performance with revenue shooting up by 31% in 2023.